Search tips
Search criteria 


Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. 1985 June 1; 161(6): 1587–1592.
PMCID: PMC2187622

Hidden autoantibodies against common serum proteins in murine systemic lupus erythematosus. Detection by in vitro plaque-forming cell assay


The autoantibodies found in human and murine systemic lupus erythematosus (SLE) are generally directed against cells or components of cells such as nuclear antigens. This predilection may be due to the unusual immunogenicity of certain autoantigens, or to unusual patterns of antibody crossreactivity. Alternatively, the observed spectrum of reactivities may reflect the in vivo absorption of those autoantibodies directed against soluble antigens. To test whether hitherto undetected autoantibodies against serum proteins might exist in murine SLE, we developed assays that were independent of the possibility of absorption of autoantibodies by serum autoantigens; large numbers of plaque- forming cells (PFC) directed against mouse albumin and mouse transferrin were easily detected in the spleens of MRL/Mp-lpr/lpr, BXSB, and NZB mice. The secreted antibodies were relatively specific for the mouse proteins, since only limited cross-reactivity was seen with albumin and transferrins of other species in inhibition experiments. The production of these hidden antibodies could not be the result of diffuse polyclonal B cell activation, since the PFC to mouse transferrins and albumin were not always accompanied by comparable numbers of PFC against related albumins and transferrins. The results indicate that autoantibody production in murine lupus is a generalized phenomenon, not limited to the production of autoantibodies to nuclear or other cell-bound antibodies. However, the relative specificity of the autoantibodies for self-antigens indicates that diffuse polyclonal B cell activation cannot be the mechanism responsible, and argues that a selective mechanism, probably driven by antigen, accounts for production of autoantibodies in SLE.

Full Text

The Full Text of this article is available as a PDF (361K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • KUNKEL HG, TAN EM. AUTOANTIBODIES AND DISEASE. Adv Immunol. 1964;27:351–395. [PubMed]
  • Pang GT, Gatman MR, Drummond JM, Booth RJ. A sensitive micromethod for measuring human reverse haemolytic plaque-forming cells. J Immunol Methods. 1981;40(3):253–258. [PubMed]
  • Goding JW. The chromic chloride method of coupling antigens to erythrocytes: definition of some important parameters. J Immunol Methods. 1976;10(1):61–66. [PubMed]
  • Primi D, Smith CI, Hammarström L, Möller G. Polyclonal B-cell activators induce immunological response to autologous serum proteins. Cell Immunol. 1977 Dec;34(2):367–375. [PubMed]
  • Primi D, Hammarström L, Smith CI, Möller G. Characterization of self-reactive B cells by polyclonal B-cell activators. J Exp Med. 1977 Jan 1;145(1):21–30. [PMC free article] [PubMed]
  • Lafer EM, Rauch J, Andrzejewski C, Jr, Mudd D, Furie B, Furie B, Schwartz RS, Stollar BD. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med. 1981 Apr 1;153(4):897–909. [PMC free article] [PubMed]
  • Izui S, McConahey PJ, Dixon FJ. Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol. 1978 Dec;121(6):2213–2219. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press